A new review highlights how molecular biology advances are reframing PAH as a complex vascular remodeling disease driven by endothelial dysfunction, chronic inflammation, metabolic dysregulation, and genetic susceptibility. Emerging therapies target the BMP/TGF-β pathway, growth factor signaling, and inflammatory pathways.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateAug 11, 2026
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
Researchers have identified a natural protective protein called BMP3 that helps maintain healthy lung blood vessels. Increasing BMP3 levels in preclinical models of pulmonary arterial hypertension reversed key features of the disease, including damaged blood vessels and impaired heart function.
SourceVirginia Tech·JournalEuropean Respiratory Journal·TypeExperimental study·DateJul 30, 2026
Researchers found that field-based homeless healthcare programs can improve the management of high blood pressure among homeless individuals, leading to a significant reduction in mortality and disability. The study suggests that these programs can have a positive impact on the health of people experiencing homelessness.
SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of General Internal Medicine·TypeData/statistical analysis·DateJun 25, 2026
A major international study has identified ways to detect patients with hypertrophic cardiomyopathy at serious risk of sudden death, heart failure or other dangerous outcomes. The findings will help save lives by improving the ability to determine who is at greatest risk and spare low-risk patients from unneeded heart implants.
A new global analysis found that nearly 90% of the increase in adults with hypertension occurred in low- and middle-income countries. Global hypertension prevalence has risen to 33%, affecting 1.7 billion people, with control rates being only about 40% globally.
SourceTulane University·JournalJournal of the American College of Cardiology·DateMay 13, 2026
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
Researchers at Kyoto University have discovered that targeting the CNP/GC-B signal pathway may provide a promising approach for treating Pulmonary Arterial Hypertension (PAH). The study reveals that CNP/GC-B signaling plays a protective role against PAH, and administration of CNP ameliorates experimental pulmonary hypertension.
SourceKyoto University·JournalNature Communications·TypeRandomized controlled/clinical trial·DateMar 17, 2026
A new study from the ECHO Program found that exposure to fine particulate matter (PM2.5) and nitrogen dioxide (NO2) before and after birth may influence childhood blood pressure patterns. High blood pressure in children is a growing concern worldwide, with nearly 80% increase over two decades.
SourceEnvironmental influences on Child Health Outcomes·JournalEnvironmental Research·TypeObservational study·DateJan 14, 2026
The Baveno VII consensus guidelines have reshaped portal hypertension management, focusing on early intervention and noninvasive diagnostics. Nonselective beta-blockers and transjugular intrahepatic portosystemic shunt (TIPS) are recommended for clinically significant portal hypertension diagnosis.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeSystematic review·DateDec 19, 2025
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
A phase 3 clinical trial found that sotatercept significantly reduces the likelihood of worsening disease in patients with severe pulmonary hypertension when added to standard treatment within the first year after diagnosis. The medication reduced the risk of deterioration by 76% and hospitalizations by nearly half.
SourceMichigan Medicine - University of Michigan·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateSep 30, 2025
Dr. Machado brings scientific expertise, clinical leadership, and mentorship to the Department of Medicine at UMSOM. He will advance research impact, enhance clinical excellence, and shape the future of academic medicine.
SourceUniversity of Maryland School of Medicine·DateJul 21, 2025
Recent studies have revealed significant improvements in patient prognosis for chronic thromboembolic pulmonary hypertension (CTEPH) over the past few decades. Advances in surgical techniques, drug development, and multimodal therapies have led to increased treatment rates and improved survival rates among patients.
SourceNational Cerebral and Cardiovascular Center·JournalEuropean Respiratory Journal·DateJul 14, 2025
A novel screening approach called VEST uses virtual echocardiography to identify patients at high risk of pulmonary arterial hypertension, a life-threatening form of heart failure. The tool has been shown to generate accurate PAH risk scores without manual calculations and can guide timely referrals for expert care.
SourceTemple University Health System·JournalAmerican Heart Journal·DateJun 4, 2025
Researchers found a 76% lower risk of death in advanced pulmonary arterial hypertension patients treated with sotatercept. The therapy significantly reduced hospitalization rates and improved patient outcomes.
SourceUniversity of Maryland School of Medicine·JournalNew England Journal of Medicine·TypeCommentary/editorial·DateMay 29, 2025
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
A phase 3 trial announced today demonstrated lorundrostat's safety and effectiveness in reducing blood pressure in patients with resistant hypertension. The treatment, which blocks the production of aldosterone from the adrenal glands, achieved clinically meaningful and sustained reductions in systolic blood pressure.
A new NIH study found that maternal cardiometabolic health before and during pregnancy is associated with higher blood pressure in children. The study analyzed data from 12,480 mother-child pairs and identified three key risk factors: pre-pregnancy obesity, gestational diabetes, and high blood pressure during pregnancy.
SourceEnvironmental influences on Child Health Outcomes·JournalJAMA Network Open·TypeObservational study·DateMay 8, 2025
Researchers developed a novel rat model that closely replicates human COPD-associated cor pulmonale, exhibiting chronic lung inflammation, pulmonary hypertension, and right ventricular hypertrophy. The model provides insights into the underlying mechanisms of disease progression and potential therapeutic targets.
SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateApr 30, 2025
A day-long conference brought together experts to present ground-breaking outcomes research on CTEPH treatments. The session covered new medications, refined techniques, and innovative approaches to improve diagnosis and treatment outcomes.
SourceInternational Society for Heart and Lung Transplantation·DateApr 26, 2025
Researchers at Penn's School of Dental Medicine and Perelman School of Medicine found that ACE inhibitors can inhibit the activity of ACE2, a critical cardioprotective enzyme. This discovery has implications for human patients prescribed these medications, who may benefit from additional ACE2 treatment.
SourceUniversity of Pennsylvania·JournalHypertension Research·TypeExperimental study·DateApr 18, 2025
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A recent study published in the International Journal of Cardiology analyzed data from multiple clinical trials to assess the therapeutic impact of pulmonary artery denervation (PADN) on pulmonary hypertension patients. PADN showed significant reductions in mean right atrial pressure, mean pulmonary artery pressure, and pulmonary vascu...
SourceOchsner Health System·JournalInternational Journal of Cardiology·DateApr 8, 2025
The ACC Advancing the Cardiovascular Care of the Oncology Patient conference will provide clinicians with tools to improve cardiovascular care of cancer patients. Key sessions will include discussions on pulmonary tumor thrombotic microangiopathy, AI and technology in cardio-oncology.
A new study suggests that adding physical activity into daily life can help lower blood pressure. Replacing sedentary behaviors with 20-27 minutes of exercise per day was estimated to lead to a clinically meaningful reduction in blood pressure, while just five minutes of activity a day was also associated with reduced levels.
SourceUniversity of Sydney·JournalCirculation·TypeObservational study·DateNov 6, 2024
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
The TIPS procedure improves renal function in patients with portal hypertension, particularly those with refractory ascites. However, the benefits of TIPS for Hepatorenal Syndrome (HRS) and Hepatopulmonary Syndrome (HPS) are limited due to insufficient data.
SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateSep 25, 2024
Researchers found that a compound from the Ardisia crenat houseplant inhibits Gq proteins, which can help relax pulmonary vessels and alleviate symptoms of pulmonary hypertension. The study showed significant vascular relaxation in mice with pulmonary hypertension, improving their health condition.
SourceRuhr-University Bochum·JournalEMBO Molecular Medicine·TypeExperimental study·DateJul 8, 2024
A recent study found that hormone replacement therapy (HRT) was associated with improved pulmonary hypertension and right ventricular function in women. The researchers analyzed data from over 700 women with pulmonary hypertension and found that those who used HRT had lower mean pulmonary artery pressure and higher right ventricular fr...
SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMay 19, 2024
Researchers discovered that IL-6 signaling in CD4-positive T cells promotes pulmonary hypertension development and progression. Treating mice with IL-6 inhibitors improved symptoms and decreased damage to the lungs and heart.
SourceNational Cerebral and Cardiovascular Center·JournalProceedings of the National Academy of Sciences·DateMay 8, 2024
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Scientists at University of Pittsburgh show that limiting glutamine and serine intake can halt disease progression in rodent models. The findings suggest a potential new therapy for patients with pulmonary hypertension, offering hope for improved treatment options beyond medications.
SourceUniversity of Pittsburgh·JournalCell Metabolism·TypeExperimental study·DateMay 2, 2024
Researchers found that riociguat significantly improved blood pressure and reduced the risk of serious adverse events compared to a placebo treatment. The study showed promising results for this potential new treatment to manage complications from sickle cell disease, paving the way for larger clinical trials.
SourceUniversity of Maryland School of Medicine·JournalThe Lancet Haematology·TypeRandomized controlled/clinical trial·DateApr 11, 2024
The Almodóvar lab is studying the link between HIV and pulmonary hypertension, a condition that increases pressure in lung arteries. By examining the interactions between different cell types and using a humanized mouse model, researchers hope to propose novel therapies to prevent lung diseases in people with HIV.
SourceTexas Tech University Health Sciences Center·DateFeb 23, 2024
A study published in Science Advances identifies a mitochondrial protein called MCJ as the first therapeutic target to preserve cardiac function in pulmonary hypertension. Modulating MCJ levels can activate a signaling pathway essential for adaptation to low oxygen levels, protecting the heart.
SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalScience Advances·TypeObservational study·DateJan 19, 2024
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
Researchers found a shared genetic trait that predicts a higher risk of small lung vessel disease and its severe form, pulmonary arterial hypertension. This discovery could lead to personalized treatments for patients with limited oxygen response.
SourceUniversity of Pittsburgh·JournalScience Translational Medicine·DateJan 10, 2024
Researchers have discovered a way to predict which individuals will respond to blood pressure treatments that lower sodium in the body. This breakthrough could lead to a 25% reduction in hypertension prevalence, resulting in significant cost savings for the Australian government.
SourceHunter Medical Research Institute·JournalCirculation·TypeData/statistical analysis·DateDec 22, 2023
Researchers have identified a new therapeutic target for pulmonary hypertension treatment by discovering an epigenetic pathway mediated via the protein SPHK2 that can reduce and potentially reverse vascular remodeling. This discovery offers new hope for treating pulmonary hypertension, which is a complex and often fatal condition.
SourceIndiana University·JournalCirculation Research·DateNov 21, 2023
A new study from Tulane University found that Black adults are 54% more likely to die of cardiovascular disease than White Americans, largely due to social factors. The study's lead author suggests that addressing unemployment, low income, and lack of a partner can help reduce this disparity.
SourceTulane University·JournalAnnals of Internal Medicine·DateAug 14, 2023
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
Researchers from Mount Sinai Health System will present studies on pediatric pulmonary vascular disease, asthma, and sleep disorders. The findings focus on prevalence of pulmonary hypertension in children with severe obstructive sleep apnea and associations between diet and lung function decline.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·DateMay 23, 2023
A long-term analysis reveals that approximately one-third of CTEPH patients also have left heart disease, which can worsen breathing symptoms and requires more comprehensive diagnostic approaches. The study suggests that treatment options for both conditions may overlap, necessitating further research to find effective therapies.
SourceMedical University of Vienna·JournalJournal of the American College of Cardiology·DateApr 27, 2023
A novel treatment approach called balloon pulmonary angioplasty has been shown to be effective in treating chronic blood clots in lung arteries. The procedure improves exercise capacity and quality of life, with some patients able to stop medications altogether. Refinements in technique have improved the procedure's safety and efficacy.
SourceTemple University Health System·JournalJACC Advances·DateApr 13, 2023
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
Researchers found decreased lung injury, coughing up blood, and mortality rates after balloon pulmonary angioplasty between 2013 and 2022. The minimally invasive procedure is now considered a safer option for inoperable CTEPH patients.
SourceMichigan Medicine - University of Michigan·JournalJACC Cardiovascular Interventions·TypeSystematic review·DateApr 5, 2023
Researchers discover that inhibiting a gene crucial for DNA production can significantly reduce destructive cell proliferation and disease progression in pulmonary hypertension. This finding presents a potential treatment target for the condition, which affects females aged 30-60 with limited treatment options.
SourceMedical College of Georgia at Augusta University·JournalEuropean Heart Journal·DateMar 14, 2023
A new biomaterial has been developed that can be injected intravenously to promote cell and tissue repair, reducing inflammation in damaged tissues. The material has shown promising results in treating heart attacks and traumatic brain injury in animal models.
SourceUniversity of California - San Diego·JournalNature Biomedical Engineering·DateJan 30, 2023
Researchers developed a novel blood test that measures cell-free DNA to evaluate PAH severity and predict survivability. The test showed significant improvement over conventional tests and may allow doctors to intervene faster to prevent disease progression.
SourceNIH/National Heart, Lung and Blood Institute·JournalCirculation·DateAug 25, 2022
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
Researchers at Temple University hospital found that maternal-fetal mortality can be reduced to zero through patient-tailored management of right heart function prior to delivery. Women with pulmonary hypertension who received specialized care had excellent outcomes, with 100% survival for mothers and infants.
SourceTemple University Health System·JournalJournal of Cardiovascular Development and Disease·DateAug 23, 2022
Researchers at UCLA have identified a gene on the Y chromosome that protects against pulmonary hypertension in men by reducing proinflammatory chemokines. The study suggests that targeting inflammation may be a promising new avenue for therapy, and could lead to effective treatments for this fatal disease.
SourceUniversity of California - Los Angeles Health Sciences·JournalAmerican Journal of Respiratory and Critical Care Medicine·TypeExperimental study·DateMay 2, 2022
A new CNIC study warns that mitochondrial therapeutic interventions can cause damage due to the mixing of mitochondrial DNAs from two distinct origins. This can lead to medium- and long-term health issues, including heart failure, pulmonary hypertension, and muscle loss.
SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalCirculation·TypeExperimental study·DateMar 16, 2022
Scientists have found that the gene PBK is overexpressed in pulmonary hypertension, causing excessive cell proliferation and thickening of pulmonary artery walls. They are now exploring PBK inhibitors to reduce cell proliferation and improve heart and lung function.
SourceMedical College of Georgia at Augusta University·DateDec 16, 2021
The study, published in Nature Aging, found that sildenafil reduces the likelihood of developing Alzheimer's disease by 69% compared to non-users. Sildenafil also shows promise in treating the disease by increasing brain cell growth and decreasing hyperphosphorylation of tau proteins.
SourceCleveland Clinic·JournalNature Aging·DateDec 6, 2021
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
Researchers at University of Pittsburgh and Prairie View A&M University developed an algorithm to repurpose cancer drugs for pulmonary hypertension, a devastating lung disease. Two compounds improved human cells and rodent markers, supporting broader drug-repurposing platform use.
SourceUniversity of Pittsburgh·JournalScience Advances·TypeExperimental study·DateOct 20, 2021
A team of scientists at Stanford University and Cincinnati Children's have found a potentially effective compound, AG1296, to treat pulmonary arterial hypertension (PAH). The compound was identified using human, PAH-specific stem cells as a drug screening platform.
SourceCincinnati Children's Hospital Medical Center·JournalScience Translational Medicine·DateMay 5, 2021
Patients with segmental CTEPH treated surgically achieved excellent outcomes, with 80% long-term survival and good quality of life. Multidisciplinary post-operative care is crucial for optimal results.
SourceAmerican Association for Thoracic Surgery·DateMay 2, 2021
The new virtual echocardiography screening tool (VEST) uses initial screening data from echocardiography to accurately diagnose pulmonary hypertension. VEST enables physicians to quickly evaluate patients for the condition by searching for routine key measures in echocardiogram reports, facilitating early recognition and timely treatment.
SourceTemple University Health System·JournalPulmonary Circulation·DateSep 17, 2020
A new treatment option shows promise in improving survival rates for babies with a rare cerebrovascular disorder. The study found that endovascular treatment can reduce the severity of pulmonary hypertension, allowing babies to cross the critical line on their way to survival.
SourceSociety of NeuroInterventional Surgery·DateAug 7, 2020
Apple iPad Pro 11-inch (M4)
Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.
Researchers from Brigham and Women's Hospital developed a new, lower threshold for pulmonary vascular resistance to diagnose patients at risk for death due to PH. The study found that 60% more patients can be diagnosed with PH using this new parameter.
SourceBrigham and Women's Hospital·JournalThe Lancet Respiratory Medicine·DateJul 28, 2020
A new study from LSU Health reveals that chronic nicotine inhalation increases blood pressure and leads to pulmonary hypertension, accompanied by changes in lung and heart blood vessels. The researchers also found the adverse effects of inhaled nicotine are largely isolated to the right heart.
SourceLouisiana State University Health Sciences Center·JournalHYPERTENSION·DateMay 1, 2020
Pulmonary hypertension caused by respiratory disease has been linked to improved health outcomes through identifying underlying conditions. Researchers at the University of Missouri have found that thorough evaluations and tailored therapy approaches can help dogs with pulmonary hypertension, increasing survival rates.
SourceUniversity of Missouri-Columbia·JournalThe Veterinary Journal·DateOct 16, 2019
Researchers at Stanford University School of Medicine have found that inflammation in the lungs can wake up a silent genetic defect that causes sudden onset cases of pulmonary hypertension. The study suggests that limiting potential environmental causes of lung inflammation may help prevent the development of the disease.
Researchers developed a cardiac MRI method to predict mortality risk in PAH patients. By monitoring right ventricular function, doctors can provide targeted therapies and measure their effectiveness.
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
The American Thoracic Society has developed a new clinical practice guideline for home oxygen therapy in children with chronic hypoxemia. The guideline makes specific recommendations for treating various respiratory and pulmonary conditions, such as cystic fibrosis, bronchopulmonary dysplasia, and interstitial lung disease.
SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateFeb 1, 2019
Researchers have identified Toll-like receptor 3 as a new target for treating pulmonary hypertension by increasing its levels through high-dose RNA stimulation, potentially reducing inflammation and cell death in the lungs.
SourceVirginia Commonwealth University·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateNov 15, 2018
Researchers have identified PFKFB3 as a key player in the development of pulmonary hypertension, a condition characterized by high blood pressure in the lungs. By targeting this enzyme, scientists hope to develop new treatments that can help alleviate symptoms and improve patient outcomes.
SourceMedical College of Georgia at Augusta University·DateMay 8, 2018
Researchers have identified FoxM1 as a potential target for treating pulmonary hypertension, a severe lung disease with a 50% five-year survival rate. Deleting the FoxM1 gene in mice resulted in thinner artery walls and improved right heart function.
SourceAnn & Robert H. Lurie Children's Hospital of Chicago·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateApr 30, 2018
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
Scientists at Johns Hopkins Medicine have made significant breakthroughs in understanding the underlying biology behind pulmonary hypertension. By studying endothelial cells, they discovered that KLF15 protects these cells from damage caused by low oxygen levels, which can lead to blood vessel damage and progression of the disease.